The civic record
Read. Follow. Verify.Utah SB 261 authorizes pharmacists to prescribe vaccines and epinephrine and permits online pseudoephedrine sales under electronic tracking
Last action · March 18, 2026: Governor SignedSponsors: Evan Vickers and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Utah SB 261 expands pharmacist prescribing authority to include vaccines and epinephrine, permits online sales of pseudoephedrine subject to a real-time electronic tracking system, and takes effect on May 6, 2026.
The measure alters how patients access specific routine medications and cold products by enabling pharmacists to issue prescriptions for vaccines and epinephrine while placing new compliance and tracking duties on retail distributors of pseudoephedrine.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Pharmacists
Pharmacists gain statutory authority to prescribe vaccines and epinephrine and must comply with updated collaborative practice and supervision standards.
Retail distributors
Retail distributors of pseudoephedrine must utilize an electronic tracking system, submit purchaser records, and adhere to stop-sale alerts for online transactions.
Patients and consumers
Patients gain expanded local access to preventive vaccines and epinephrine prescriptions from pharmacists while facing identity verification and tracking requirements when purchasing pseudoephedrine online.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Can pharmacists now prescribe vaccines and epinephrine in Utah?
What is required for online sales of pseudoephedrine under the new law?
What happens if a free electronic tracking system is not available?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
44 actions- Mar 18, 2026Lieutenant Governor's office for filingEnrolledGovernor Signed
- Mar 13, 2026SenateSenate/ to Governor
- Mar 13, 2026SenateSenate/ received enrolled bill from Printing
- Mar 12, 2026SenateSenate/ enrolled bill to Printing
- Mar 12, 2026Senate SecretaryEnrolled Bill Returned to House or Senate
- Mar 10, 2026Legislative Research and General Counsel / EnrollingDraft of Enrolled Bill Prepared
Show 38 earlier actions
- Mar 10, 2026Legislative Research and General Counsel / EnrollingBill Received from Senate for Enrolling
- Mar 10, 2026SenateSenate/ signed by President/ sent for enrolling
- Mar 10, 2026SenateSenate/ received from House
- Mar 6, 2026HouseHouse/ to Senate
- Mar 6, 2026HouseHouse/ signed by Speaker/ returned to Senate
- Mar 6, 2026HouseFloorHouse/ passed 3rd reading
- Mar 6, 2026HouseHouse/ 3rd reading
- Mar 6, 2026HouseHouse/ Rules to 3rd Reading Calendar
- Mar 3, 2026HouseHouse/ 3rd Reading Calendar to Rules
- Mar 3, 2026HouseHouse/ 2nd reading
- Mar 3, 2026HouseHouse/ committee report favorable
- Mar 3, 2026HouseHouse Comm - Favorable Recommendation
- Mar 2, 2026HouseCommitteeHouse/ to standing committee
- Mar 2, 2026HouseIntroducedHouse/ 1st reading (Introduced)
- Feb 27, 2026HouseHouse/ received from Senate
- Feb 27, 2026SenateSenate/ to House
- Feb 25, 2026SenateFloorSenate/ passed 3rd reading
- Feb 25, 2026SenateSenate/ 3rd reading
- Feb 24, 2026SenateFloorSenate/ passed 2nd reading
- Feb 24, 2026SenateSenate/ 2nd reading
- Feb 17, 2026SenateSenate/ placed on 2nd Reading Calendar
- Feb 17, 2026SenateSenate/ comm rpt/ substituted
- Feb 13, 2026ReleasedLFA/ fiscal note publicly available for SB0261S01
- Feb 12, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0261S01
- Feb 12, 2026SenateSenate Comm - Favorable Recommendation
- Feb 12, 2026SenateSenate Comm - Substitute Recommendation
- Feb 11, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0261S01
- Feb 11, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0261S01
- Feb 10, 2026SenateSenate/ received fiscal note from Fiscal Analyst
- Feb 10, 2026ReleasedLFA/ fiscal note publicly available for SB0261
- Feb 9, 2026SenateCommitteeSenate/ to standing committee
- Feb 9, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0261
- Feb 6, 2026SenateIntroducedSenate/ 1st reading (Introduced)
- Feb 6, 2026SenateSenate/ received bill from Legislative Research
- Feb 6, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0261
- Feb 6, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0261
- Feb 6, 2026Legislative Research and General CounselNumbered Bill Publicly Distributed
- Feb 6, 2026Legislative Research and General CounselBill Numbered but not Distributed
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Pharmacist Clinical Scope
The legislation broadens the independent clinical role of pharmacists in Utah by explicitly incorporating vaccines and epinephrine into prescribing privileges.
Connected Entities
Sources
le.utah.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools